X-ray Crystallographic Structure of a Teixobactin Derivative Reveals Amyloid-like Assembly
- PMID: 30296063
- PMCID: PMC6356018
- DOI: 10.1021/jacs.8b07709
X-ray Crystallographic Structure of a Teixobactin Derivative Reveals Amyloid-like Assembly
Abstract
This paper describes the X-ray crystallographic structure of a derivative of the antibiotic teixobactin and shows that its supramolecular assembly through the formation of antiparallel β-sheets creates binding sites for oxyanions. An active derivative of teixobactin containing lysine in place of allo-enduracididine assembles to form amyloid-like fibrils, which are observed through a thioflavin T fluorescence assay and by transmission electron microscopy. A homologue, bearing an N-methyl substituent, to attenuate fibril formation, and an iodine atom, to facilitate X-ray crystallographic phase determination, crystallizes as double helices of β-sheets that bind sulfate anions. β-Sheet dimers are key subunits of these assemblies, with the N-terminal methylammonium group of one monomer and the C-terminal macrocycle of the other monomer binding each anion. These observations suggest a working model for the mechanism of action of teixobactin, in which the antibiotic assembles and the assemblies bind lipid II and related bacterial cell wall precursors on the surface of Gram-positive bacteria.
Figures
References
-
- Ling LL; Schneider T; Peoples AJ; Spoering AL; Engels I; Conlon BP; Mueller A; Schäberle TF; Hughes DE; Epstein S; Jones M; Lazarides L; Steadman VA; Cohen DR; Felix CR; Fetterman KA; Millett WP; Nitti AG; Zullo AM; Chen C; Lewis K A new antibiotic kills pathogens without detectable resistance. Nature 2015, 517, 455–459. - PMC - PubMed
-
- Zong Y; Sun X; Gao H; Meyer KJ; Lewis K; Rao Y Developing Equipotent Teixobactin Analogues against Drug-Resistant Bacteria and Discovering a Hydrophobic Interaction between Lipid II and Teixobactin. J. Med. Chem. 2018, 61, 3409–3421. - PubMed
-
- Parmar A; Lakshminarayanan R; Iyer A; Mayandi V; Leng Goh ET; Lloyd DG; Chalasani MLS; Verma NK; Prior SH; Beuerman RW; Madder A; Taylor EJ; Singh I Design and Syntheses of Highly Potent Teixobactin Analogues against Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococci (VRE) in Vitro and in Vivo. J. Med. Chem. 2018, 61, 2009–2017. - PubMed
